Gene Editing Market Revenue Forecast 2020-2026 By Regional Manufacturers

Gene Editing Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.

The gene editing market is forecast to observe tremendous growth owing to the increasing government-sponsored regulatory support for more effective and better treatments for genetic disorders. This government support is a response to the rapidly growing prevalence of different genetic diseases throughout the globe.

Consequently, regulatory agencies are increasingly partnering with other organizations to grant a helping hand to the development of affordable gene therapies that treat diseases like HIV and sickle cell anemia. Citing an instance, in 2019, the National Institutes of Health as well as the Bill & Melinda Gates Foundation teamed up to invest $100 million each to help with the development of more affordable and effective gene therapies and make them readily available worldwide.  

Request for a sample copy of this report @

As per a research report by GMI Inc., the gene editing market is likely to exceed a valuation of $10 billion by the end of 2026.  

Tools like CRISPR-Cas9 are widely used by researchers given to its efficiency and simplicity in gene slicing. Increasing emergence of technologies like Crispr gene editing could enhance the adoption of gene editing in newer markets.

In terms of application, the gene editing industry is mainly bifurcated into plant genetic engineering, animal genetic engineering and cell gene engineering. Among these, the plant genetic engineering segment held almost 19% of the market share in 2019, and is expected to maintain progressive growth over the forecast period.

Growing inclination towards genetically modified crops supported by increasing availability of modern gene editing practices in plant genome could play a vital role in accelerating technology demand. Genetically modified plants and crops have numerous benefits in terms of eliminating the need for environmentally harmful pesticides and improving agricultural productivity.

On the regional front, Asia Pacific is considered to be a prominent region for gene editing providers. It is estimated that the APAC gene editing market may register more than 15% CAGR within the analysis period. Genetic research enterprises across emerging countries in APAC are emphasizing on developing innovative gene editing tools. Rising number of gene editing-related research activities in Japan, China and India could broaden the industry perspective over the forecast timeframe.

Request for customization @

Companies operating in the gene editing industry are focusing on a number of growth strategies like private or public funding, mergers, collaborations and novel product launches to enhance their production capacities and geographical reach. Taking September 2020 for instance, Graphite Bio secured a funding of $45 million from an initial financing round to develop its gene editing solution for treating genetic conditions like sickle cell disease.

Currently, companies like Horizon Discovery, Integrated DNA Technologies, Takara Bio, Agilent Technologies, Thermo Fisher Scientific, Sangamo Therapeutics, EMD Millipore (Merck KGAa), Precision Biosciences Inc., Caribou Biosciences, Origene Technologies, and Beam Therapeutics are leading the industry landscape with their pioneering products and services.  

Partial Chapter of the Table of Content 

Chapter 2.    Executive Summary

2.1. Gene editing industry 3600 synopsis, 2015 - 2026

2.1.1.    Business trends

2.1.2.    Application trends

2.1.3.    Technology trends

2.1.4.    End-user trends

2.1.5.    Regional trends

Chapter 3.    Gene Editing Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2015 - 2026

3.3. Industry impact forces

3.3.1.    Growth drivers    Increased funding for genetic research in North America    Rising R&D expenditure and growth of biotechnology in Europe    Increasing demand for synthetic genes in Asia Pacific and North America    Technology advancements in gene editing in North America

3.3.2.    Industry pitfalls and challenges    Stringent government regulations    Lack of public awareness in underdeveloped economies

3.4. Growth potential analysis

3.4.1.    By application

3.4.2.    By technology

3.4.3.    By end-user

3.5. COVID-19 impact analysis

3.6. Competitive landscape, 2019

3.6.1.    Strategy dashboard, 2019

3.7. Porter’s analysis

3.8. PESTEL analysis 

Browse full table of contents (TOC) of this report @